The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease

来源 :中国神经再生研究(英文版) | 被引量 : 0次 | 上传用户:st65210163
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
Leukemia inhibitory factor receptor (LIFR), as a neuroregulatory cytokine receptor, generally shows a neuroprotective effect in central nervous system injuries.
Among collagen members in the collagen superfamily, type XIX collagen has raised increasing interest in relation to its structural and biological roles. Type XI
Stroke persists as a global health and economic crisis, yet only two interventions to reduce stroke-induced brain injury exist. In the clinic, many patients who
10.4103/1673-5374.270163rnIn the article titled Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease, published on pages
期刊
Multiple sclerosis (MS) is a T-cell-mediated autoimmune disease of the central nervous system (CNS). Worldwide, more than 2.3 million peo-ple are diagnosed with
期刊
Alzheimer’s disease (AD) is a progressive neurodegenerative dis-order and the predominant form of dementia. Since its initial de-scription by Alois Alzheimer i
期刊
Oxidative stress contributes to the pathogenesis of neurodegenerative diseases. With the aim to find reagents that reduce oxidative stress, a phage display libr
期刊
Retinoic acid can cause many types of cells, including mouse neuroblastoma Neuro-2A cells, to differentiate into neurons. However, it is still unknown whether m
Brain-derived neurotrophic factor (BDNF) has robust effects on synaptogenesis, neuronal differentiation and synaptic transmission and plasticity. The maturation